Astera Labs (NASDAQ:ALAB) Given New $230.00 Price Target at Susquehanna

Astera Labs (NASDAQ:ALAB) had its price target hoisted by Susquehanna from $155.00 to $230.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. Susquehanna’s price target points to a potential upside of 11.01% from the company’s current price.

A number of other research analysts have also recently issued reports on ALAB. Rothschild & Co Redburn initiated coverage on Astera Labs in a report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price target for the company. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $250.00 price target on shares of Astera Labs in a report on Tuesday, April 21st. Jefferies Financial Group reaffirmed a “buy” rating and issued a $270.00 price target on shares of Astera Labs in a report on Wednesday. Stifel Nicolaus lifted their price target on Astera Labs from $236.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday. Finally, Needham & Company LLC lifted their price target on Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday. Fifteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $216.15.

Astera Labs Stock Performance

Shares of NASDAQ:ALAB traded down $8.50 on Wednesday, hitting $207.20. The stock had a trading volume of 3,184,246 shares, compared to its average volume of 5,314,226. Astera Labs has a twelve month low of $63.40 and a twelve month high of $262.90. The firm’s 50 day moving average price is $140.72 and its 200-day moving average price is $153.38. The company has a market capitalization of $35.49 billion, a price-to-earnings ratio of 169.55, a price-to-earnings-growth ratio of 3.96 and a beta of 3.35.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The company had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same quarter in the previous year, the company earned $0.33 EPS. The firm’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, sell-side analysts predict that Astera Labs will post 1.48 EPS for the current year.

Insider Activity at Astera Labs

In other news, General Counsel Philip Mazzara sold 10,000 shares of the business’s stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $107.77, for a total transaction of $1,077,700.00. Following the completion of the transaction, the general counsel directly owned 118,084 shares in the company, valued at approximately $12,725,912.68. The trade was a 7.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Michael Truett Tate sold 12,001 shares of the business’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $1,485,843.81. Following the transaction, the chief financial officer owned 192,083 shares of the company’s stock, valued at $23,781,796.23. The trade was a 5.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 1,064,888 shares of company stock worth $150,764,723. 12.50% of the stock is owned by company insiders.

Hedge Funds Weigh In On Astera Labs

Several institutional investors have recently modified their holdings of ALAB. Assetmark Inc. grew its position in shares of Astera Labs by 374.1% during the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after buying an additional 101 shares during the period. Reflection Asset Management acquired a new position in shares of Astera Labs in the 4th quarter valued at approximately $25,000. Smartleaf Asset Management LLC grew its position in shares of Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after purchasing an additional 152 shares during the period. Hilltop National Bank grew its position in shares of Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after purchasing an additional 100 shares during the period. Finally, Aventura Private Wealth LLC acquired a new position in shares of Astera Labs in the 4th quarter valued at approximately $33,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q1 results: Astera Labs posted a multi‑point beat — $0.61 EPS vs. $0.54 consensus and revenue of $308.4M (+93% YoY). Management highlighted record revenue and expanding margins, which validates current growth expectations. Astera Labs Bulls Stay In Control Following Earnings Double Beat, Strong Q2 Guidance
• Positive Sentiment: Raised Q2 guidance: Company issued Q2 EPS guide of $0.68–$0.70 and revenue guide ($355M–$365M) well above street estimates, creating strong forward visibility for next quarter. Astera Labs Reports First Quarter 2026 Financial Results
• Positive Sentiment: New product momentum: Astera began shipping the Scorpio X‑Series 320‑lane smart fabric switch to hyperscalers — strengthens position in AI scale‑up networking and supports future revenue growth. Astera Labs Extends Leadership in Open, AI Scale-Up Networking with New 320 Lane Scorpio X-Series Smart Fabric Switch
• Positive Sentiment: Analyst upgrades/price‑target lifts: Stifel Nicolaus and Needham raised targets to $260 and maintain buy ratings, supplying fresh buy‑side momentum and signaling increased sell‑side conviction. Benzinga
• Positive Sentiment: Market commentary and investor interest: Several outlets and commentators (Seeking Alpha, TipRanks, MarketWatch, Jim Cramer mention) highlighted robust AI demand and the company’s strategic role in accelerator connectivity, helping sentiment. Astera Labs: Superb Q1, But Faster Times Ahead
• Neutral Sentiment: Earnings call / transcripts available: Investors can review the Q1 earnings transcript for detail on product roadmap, gross‑margin dynamics and hyperscaler engagements to assess sustainability of the beat. Astera Labs, Inc. (ALAB) Q1 2026 Earnings Call Transcript
• Negative Sentiment: Valuation questions: Coverage notes and a valuation piece flag that recent momentum has pushed multiples higher (ALAB sports a high P/E and elevated beta), so upside is contingent on continued outsized execution — raising short‑term risk of multiple contraction if growth slows. Assessing Whether Astera Labs (ALAB) Is Overvalued After Its Strong Recent Share Price Momentum

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.